Aclaris Therapeutics, Inc. (ACRS) vs Aura Biosciences, Inc. (AURA)
A side-by-side comparison of Aclaris Therapeutics, Inc. and Aura Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACRS
Aclaris Therapeutics, Inc.
$4.05HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
AURA
Aura Biosciences, Inc.
$6.17HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
Total return — ACRS vs AURA
growth of $100 · dividends reinvested · last 5yACRS -74.5% (-23.9%/yr)AURA -58.0% (-15.9%/yr)AURA compounded faster over this window
ACRS AURA
ACRS vs AURA: by the numbers
- •AURA is the larger company ($638M vs $566M market cap).
- •Both run net losses; AURA's is the smaller (0.00% vs -921.50% net margin).
Metrics side by side
Valuation
| Metric | ACRS | AURA |
|---|---|---|
| P/S ratio | 68.82 | N/A |
| P/B ratio | 4.54 | 2.02 |
Profitability
| Metric | ACRS | AURA |
|---|---|---|
| Gross margin | 73.28% | 0.00% |
| Operating margin | -975.91% | 0.00% |
| Net margin | -921.50% | 0.00% |
| ROE | -60.79% | -41.56% |
| ROIC | -56.99% | -42.02% |
Growth (annualized)
| Metric | ACRS | AURA |
|---|---|---|
| Revenue CAGR (5Y) | 4.39% | N/A |
| Total return CAGR (5Y) | -24.23% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.